Track the CLARITY PHARMACEUTICALS LTD share price and the full management transaction log of the company, a publicly traded company based in Australia. Shares are quoted on the AU market, under the authority of ASX. Market capitalisation: €981.2m. The latest transaction was filed on 12 August 2026 (Cease Substantial Holding). Among the most active insiders: 2. Changes in relevant interests. All data is accessible without an account.
9
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate CLARITY PHARMACEUTICALS LTD Strong Buy (bullish), based on 4 analysts. Average price target: A$7.20.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
CLARITY PHARMACEUTICALS LTD es una empresa centrada en el desarrollo de tratamientos innovadores para enfermedades graves. Cotiza en la Bolsa de Valores de Australia (XASX).